NCT07530744 2026-04-15
Cronos
Elisabethinen Hospital
Phase NA Not yet recruiting
Clinical Trials
14 trialsNCT03606070 2026-03-23
IMAHTEP
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Terminated
NCT06576635 2026-01-20
LUNG-05
University of Illinois at Chicago
Phase NA Recruiting
NCT07247227 2025-11-25
Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC
Peking Union Medical College
Phase NA Recruiting
NCT06457789 2025-04-02
iRelate
Amsterdam UMC, location VUmc
Phase NA Recruiting
NCT06739031 2024-12-18
Clinical Trial to Evaluate the Efficacy and Safety of Pulsed Electric Field Ablation Devices in the Treatment of Lung Tumors
Energenx Medical LTD.
Phase NA Not yet recruiting
NCT05987345 2024-07-22
Trial of Pulsed Electric Field Therapy in Patients With Late-stage Non-small Cell Lung Cancer
Energenx Medical LTD.
Phase NA Recruiting
NCT02869685 2024-02-23
RadImm02
Xinqiao Hospital of Chongqing
Phase NA Completed
NCT02890849 2024-02-23
RadImm01
Xinqiao Hospital of Chongqing
Phase NA Completed
NCT05999214 2023-09-25
99mTc-H7ND SPECT/CT Imaging in NSCLC
First Affiliated Hospital Xi'an Jiaotong University
Phase NA Recruiting
NCT04720339 2022-11-23
Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy.
University Hospital, Strasbourg, France
Phase NA Recruiting
NCT02354274 2022-04-25
Novel Approach to Radiotherapy in Locally Advanced Lung Cancer Concomitant NavelbineĀ®
Odense University Hospital
Phase NA Recruiting
NCT04007835 2019-07-05
Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI
Guangdong Association of Clinical Trials
Phase NA Unknown
NCT02315053 2017-10-27
PET Response During Chemoradiation of Lung Cancer
The Netherlands Cancer Institute
Phase NA Completed